Utah Medical Products Inc
UTMD- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000706698
In the last 90 days, Utah Medical Products Inc insiders filed 1 open-market purchase and 0 sales; 116 institutions reported holding it in 13F filings for Q2 2026, worth $159.9M in total; no superinvestor holds it.
Key figures
- Market capClose on Nov 11, 2026
- $232.5M
- Insider buysLast 90 days, $66.8K in total
- 1
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, −2 vs. previous quarter
- 116
- 13F valueReported value at the end of Q2 2026
- $159.9M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $38.5M
- −5.8% year over year
- Net income, FY2025
- $11.3M
- −18.7% year over year
- Free cash flow, FY2025
- $14.3M
- −1.9% year over year
- Revenue, Q2 FY2026
- $8.53M
- −14.3% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 151.3K
- Shares sold short
- Change
- +11.1K
- +7.9% vs. previous
- Days to cover
- 3.90
- At average daily volume
Superinvestors holding UTMD, Q2 2026
Go to the superinvestors tabNo superinvestor reported holding UTMD at the end of Q2 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Utah Medical Products Inc insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 29, 2026 (view filing)4:46 PM ET | Oct 29 | Same day | Cornwell Kevin LChairman, CEO | PPurchase | +1.00K | $66.75 | +$66.8K | +0.5%189.5K after | |
| May 19, 2023 (view filing) | May 18 | 1 day | Richins Paul ODirector | SSale | −700 | $93.47 | −$65.4K | −3.2%21.5K after | |
| Nov 21, 2022 (view filing) | Nov 18 | 3 days | Richins Paul ODirector | SSale | −449 | $90.81 | −$40.8K | −2.0%22.3K after | |
| Nov 17, 2022 (view filing) | Nov 17 | Same day | Richins Paul ODirector | SSale | −161 | $90.00 | −$14.5K | −0.7%22.8K after | |
| Nov 15, 2022 (view filing) | Nov 11 | 4 days | Richins Paul ODirector | SSale | −40 | $92.50 | −$3.70K | −0.2%22.9K after | |
| May 11, 2022 (view filing) | May 11 | Same day | Payne Barbara ADirector | SSale | −2.00K | $85.20 | −$170.4K | −27.3%5.34K after | |
| Nov 26, 2021 (view filing) | Nov 23-24 | 3 days | Hoyer Ernst GDirector | SSale | −5.00K | $126.38 | −$631.9K | −50.0%5.00K after | 2 lots |
| Nov 18, 2021 (view filing) | Nov 17-18 | 1 day | Payne Barbara ADirector | SSale | −2.00K | $111.06 | −$222.1K | −20.3%7.84K after | 2 lots |
| Aug 30, 2021 (view filing) | Aug 27-30 | 3 days | Payne Barbara ADirector | SSale | −2.00K | $88.24 | −$176.4K | −16.9%9.84K after | 2 lots |
| Aug 27, 2021 (view filing) | Aug 25 | 2 days | Payne Barbara ADirector | SSale | −1 | $88.00 | −$88 | 0.0%11.8K after |
Top 10 13F holders, Q2 2026
See all 116 holdersThe largest institutional positions in Utah Medical Products Inc at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Brandes Investment Partners, LP | 475,158 | $32.8M | 0.23% | +25,879+5.8% | Added |
| BlackRock, Inc. | 203,690 | $14.1M | 0.00% | +16,041+8.5% | Added |
| Dimensional Fund Advisors LP | 198,817 | $13.7M | 0.00% | +909+0.5% | Added |
| Renaissance Technologies LLC | 175,814 | $12.1M | 0.02% | −8,300−4.5% | Reduced |
| Vanguard Capital Management LLC | 134,535 | $9.28M | 0.00% | −4,025−2.9% | Reduced |
| Geode Capital Management, LLC | 108,048 | $7.45M | 0.00% | −12,049−10.0% | Reduced |
| Minerva Advisors LLC | 93,615 | $6.46M | 4.08% | 00.0% | Unchanged |
| Hotchkis & Wiley Capital Management LLC | 85,231 | $5.88M | 0.02% | −3,900−4.4% | Reduced |
| Rice Hall James & Associates, LLC | 71,363 | $4.92M | 0.24% | +3,481+5.1% | Added |
| Morgan Stanley | 69,671 | $4.81M | 0.00% | +20,870+42.8% | Added |
Holders of 5% or more of UTMD
See all 4 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Utah Medical Products Inc.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Brandes Investment Partners, LP | 13G/A | 14.90%475.2K shares | +0.80 ppfrom 14.10% | May 14, 20255 filings | Aug 14, 2026 | SEC |
| Dimensional Fund Advisors LP | 13G/A | 6.10%197.5K shares | – | Oct 31, 20242 filings | Jul 15, 2025 | SEC |
| Renaissance Technologies LLC | 13G/A | 5.52%175.8K shares | −1.18 ppfrom 6.70% | Feb 11, 20216 filings | Aug 13, 2026 | SEC |
| BlackRock, Inc. | 13G | 5.30%172.7K shares | +0.33 ppfrom 4.97% | Feb 5, 20252 filings | Jul 17, 2025 | SEC |